Your browser doesn't support javascript.
loading
Prior Antibodies to Infliximab or Adalimumab Are Related to Immunogenicity to Vedolizumab in Patients With Inflammatory Bowel Disease.
Papamichael, Konstantinos; Vande Casteele, Niels; Abraham, Bincy P; Ritter, Timothy; Jain, Anjali; Cheifetz, Adam S.
Afiliação
  • Papamichael K; Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts. Electronic address: kpapamic@bidmc.harvard.edu.
  • Vande Casteele N; Department of Medicine, University of California San Diego, La Jolla, California.
  • Abraham BP; Department of Medicine, Houston Methodist Hospital, Houston, Texas.
  • Ritter T; GI Alliance Research, Southlake, Texas.
  • Jain A; Prometheus Laboratories, San Diego, California.
  • Cheifetz AS; Center for Inflammatory Bowel Disease, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Clin Gastroenterol Hepatol ; 21(11): 2978-2980.e2, 2023 10.
Article em En | MEDLINE | ID: mdl-36372372
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Colite Ulcerativa Idioma: En Ano de publicação: 2023 Tipo de documento: Article